The dialysis equipment market in India is driven by a large and growing population, an aging demographic, and a significant burden of chronic diseases. The country is undergoing a substantial demographic shift, with the proportion of individuals aged 60 and above expected to more than double between 2011 and 2036, as reported in a January 2025 analysis. This increase in the elderly population contributes to a higher prevalence of age-related health issues, including chronic kidney disease (CKD).
CKD has become a major public health concern in India. A systematic review published on PubMed, referencing data up to 2023, highlighted a rise in CKD prevalence among individuals aged 15 and above, reaching 16.38% between 2018 and 2023—significantly higher than in previous years. This trend is closely linked to the widespread incidence of diabetes and hypertension. The Indian Council of Medical Research's (ICMR) INDIAB study, published in 2023, found that diabetes affected 10.1 crore individuals, while a February 2024 PubMed publication revealed that hypertension is also on the rise, with a crude prevalence of 25.3% for hypertension and 7.5% for diabetes among a study group of 1.3 million adults (based on data up to 2018). These factors contribute directly to the increasing number of people requiring renal replacement therapy.
While exact and centralized national data on dialysis patients for 2023–2024 is limited, estimates suggest that around 200,000 new patients are diagnosed with end-stage kidney disease (ESKD) annually, requiring dialysis or a transplant, as reported by the Times of India in March 2025 based on the Maharashtra Economic Survey.
Given the vast scale of the affected population, combined with rising risk factors and government efforts to expand dialysis access through programs like the PMNDP, there is a growing and persistent demand for dialysis equipment, consumables, and skilled healthcare personnel throughout India.
The dialysis equipment market in India is driven by a large and growing population, an aging demographic, and a significant burden of chronic diseases. The country is undergoing a substantial demographic shift, with the proportion of individuals aged 60 and above expected to more than double between 2011 and 2036, as reported in a January 2025 analysis. This increase in the elderly population contributes to a higher prevalence of age-related health issues, including chronic kidney disease (CKD).
CKD has become a major public health concern in India. A systematic review published on PubMed, referencing data up to 2023, highlighted a rise in CKD prevalence among individuals aged 15 and above, reaching 16.38% between 2018 and 2023—significantly higher than in previous years. This trend is closely linked to the widespread incidence of diabetes and hypertension. The Indian Council of Medical Research's (ICMR) INDIAB study, published in 2023, found that diabetes affected 10.1 crore individuals, while a February 2024 PubMed publication revealed that hypertension is also on the rise, with a crude prevalence of 25.3% for hypertension and 7.5% for diabetes among a study group of 1.3 million adults (based on data up to 2018). These factors contribute directly to the increasing number of people requiring renal replacement therapy.
While exact and centralized national data on dialysis patients for 2023–2024 is limited, estimates suggest that around 200,000 new patients are diagnosed with end-stage kidney disease (ESKD) annually, requiring dialysis or a transplant, as reported by the Times of India in March 2025 based on the Maharashtra Economic Survey.
Given the vast scale of the affected population, combined with rising risk factors and government efforts to expand dialysis access through programs like the PMNDP, there is a growing and persistent demand for dialysis equipment, consumables, and skilled healthcare personnel throughout India.
The dialysis equipment market in India is driven by a large and growing population, an aging demographic, and a significant burden of chronic diseases. The country is undergoing a substantial demographic shift, with the proportion of individuals aged 60 and above expected to more than double between 2011 and 2036, as reported in a January 2025 analysis. This increase in the elderly population contributes to a higher prevalence of age-related health issues, including chronic kidney disease (CKD).
CKD has become a major public health concern in India. A systematic review published on PubMed, referencing data up to 2023, highlighted a rise in CKD prevalence among individuals aged 15 and above, reaching 16.38% between 2018 and 2023—significantly higher than in previous years. This trend is closely linked to the widespread incidence of diabetes and hypertension. The Indian Council of Medical Research's (ICMR) INDIAB study, published in 2023, found that diabetes affected 10.1 crore individuals, while a February 2024 PubMed publication revealed that hypertension is also on the rise, with a crude prevalence of 25.3% for hypertension and 7.5% for diabetes among a study group of 1.3 million adults (based on data up to 2018). These factors contribute directly to the increasing number of people requiring renal replacement therapy.
While exact and centralized national data on dialysis patients for 2023–2024 is limited, estimates suggest that around 200,000 new patients are diagnosed with end-stage kidney disease (ESKD) annually, requiring dialysis or a transplant, as reported by the Times of India in March 2025 based on the Maharashtra Economic Survey.
Given the vast scale of the affected population, combined with rising risk factors and government efforts to expand dialysis access through programs like the PMNDP, there is a growing and persistent demand for dialysis equipment, consumables, and skilled healthcare personnel throughout India.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook